Omada Health, Inc. has disclosed a transaction involving restricted stock units (RSUs) granted to its director, Julie Klapstein. This filing is significant as it illustrates the company's approach to executive compensation and aligns with broader trends in the health services industry.
Background
Founded in South San Francisco, Omada Health, Inc. operates within the health services sector, classified under SIC 8000. The company trades on the Nasdaq under the ticker symbol OMDA. As an emerging growth company, Omada Health focuses on providing digital health solutions to improve chronic disease management.
What the Filing Says
According to the recent filing dated October 7, 2026, Klapstein acquired 549 shares through RSUs on October 5, 2026. The filing notes, "Represents restricted stock units ('RSUs') that were granted pursuant to the Issuer's Non-Employee Director Compensation Program in lieu of retainer fees." Following this transaction, Klapstein owns a total of 22,514 shares.
Impact
This transaction may affect stakeholders, including shareholders and potential investors, as it reflects the company's commitment to aligning director compensation with shareholder interests. The health services industry continues to evolve, with companies like Omada Health adapting their compensation structures to attract and retain key talent.
What's Next
The filing does not say what happens next.